abstract |
The invention relates to substituted cyclodextrins comprising at least one substituent -S-(Cn-alkylene)-R and pharmaceutically acceptable salts thereof, pharmaceutical compositions, kits of parts and their use as procoagulants. The invention further relates to said cyclodextrins for use in methods of reversing an anticoagulant effect of an anticoagulant in a subject, in methods for reducing or preventing bleeding in a subject and in methods for the treatment or prevention of a blood coagulation disorder. |